ENZC (Enzolytics) Common Stock: $0.00 Mil (As of Jun. 2011)


What is Enzolytics Common Stock?

Enzolytics ENZC -10.00% Common Stock is $0.00 Mil as of Jun. 2011.

Enzolytics's quarterly common stock stayed the same from Dec. 2010 ($0.00 Mil) to Mar. 2011 ($0.00 Mil) and stayed the same from Mar. 2011 ($0.00 Mil) to Jun. 2011 ($0.00 Mil).

Enzolytics's annual common stock declined from Jul. 2008 ($0.00 Mil) to Dec. 2009 ($0.00 Mil) but then increased from Dec. 2009 ($0.00 Mil) to Dec. 2010 ($0.00 Mil).

Enzolytics Common Stock Historical Data

* Premium members only.

The historical data trend for Enzolytics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzolytics Common Stock Chart

Enzolytics Annual Data
Trend Dec07 Jul08 Dec09 Dec10
Common Stock
0.18 0.00 0.00 0.00

Enzolytics Quarterly Data
Sep07 Dec07 Apr08 Jul08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Enzolytics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.00 Mil mean?
Enzolytics (ENZC) has a Common Stock of $0.00 Mil as of Jun. 2011. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Enzolytics and its competitors.
Is Enzolytics' Common Stock too high?
Enzolytics' current Common Stock is $0.00 Mil.
How does Enzolytics' Common Stock compare to competitors?
Enzolytics' Common Stock of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Enzolytics and its competitors. Enzolytics's current Common Stock is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enzolytics stock overvalued right now?
Enzolytics (ENZC) has a current Common Stock of $0.00 Mil. The current Common Stock is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Enzolytics (ENZC), the current Common Stock is $0.00 Mil as of Jun. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enzolytics Business Description

Address 1101 Raintree Circle, Suite 130, Allen, TX, USA, 75013
Enzolytics Inc is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The company is committed to creating drugs for the good health of mankind. ENZC's flagship compound, ITV-1, is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use.